The BMTF aims to provide an environment in which the existing research expertise from partners and collaborators will come together to create critical mass in collaborative multidisciplinary research teams, to develop new materials for devices, diagnostics, delivery technologies, imaging agents and the assessment of these materials through new, non-invasive, in situ imaging techniques.
Development of innovative device solutions for a range of medical disorders, including Parkinson's disease, epilepsy, essential tremor and Obsessive Compulsive Disorder
DNA constructs are electroporated in our facility into mouse or rat ES cells. After selection, clones are picked and screened by Southern Blot. The correctly targeted clones are then thawed and expanded and only after re-confirmation by Southern and sequencing, they are injected into blastocysts by the Transgenic Services at Monash.
Featuring a wide range of capabilities in surface modification, thin films, polymer grafting, biomolecule immobilisation and bioactive coatings in polymers, ceramics and metals.
Two biological isolator facilities have been established to facilitate clinical development of human cell-based therapies. Established under the auspices of the Victorian Consortium for Cell-based Therapies (VCCT), the isolators provide a complete barrier from environmental and operator-borne contamination and are therefore ideally suited for aseptic processing.
Leaders in neuropathology and experimental tissue preparation for histological analysis.
An industry leader in imaging, flow cytometry, project design, analysis and training providing easy, open access to equipment and experienced staff for researchers from any field
The SCA Stem Cell Core facility at the Melbourne Brain Centre provides essential services for Australian scientists using pluripotent stem cells in their research. SCA resources support bioengineering, nanotechnology, stem cell biology, advanced molecular analysis and clinical research activities
The MPEF is a unique facility that can produce small to large amounts of high quality recombinant proteins and antibodies for use in medical research.
Histology, optical microscopy, electron microscopy and image analysis.
The Monash Protein Production Unit is a specialised protein production and purification facility. We have expertise in the production of recombinant proteins involving the generation of DNA constructs through to biophysical analysis of recombinant purified proteins.
Monash Histology Platform is a world class, full service Histology Laboratory partnering for success in research, education and clinical results. Located within the Department of Anatomy and Developmental Biology, the Platform provides expert service, advice and training to internal and external clients for all histological studies involving fresh tissue and tissue embedded in paraffin, resin and glycolmethacrylate.
MATF is a global source of cost effective, high quality, high affinity, custom monoclonal antibodies. We are known for our ability to succeed at challenging projects and strive to be the best at producing monoclonal antibodies where others have failed.
High-content screening at Monash Health Translation Precinct
The HTCS Facility houses a Lead Discovery library currently containing ~200,000 compounds and robotics platforms to screen these small molecule chemical entities against biological targets of interest for drug discovery or for chemical biology outcomes
The Australian Phenomics Network (APN) brings together multiple services with world-class infrastructure and expertise for the creation, characterisation and cryopreservation of mouse models of human disease. Generous funding from Federal/ State government, research institutions and NHMRC means the APN can offer researchers access to services at a greatly reduced cost.
The ISO9001 certified Recombinant Protein Production Facility (RPPF) provides Australian researchers with subsidised access to state-of-the-art facilities for large scale protein production, process development and optimisation using mammalian cell culture, fungal and microbial expression systems.
The Burnet ImmunoMonitoring Facility is accredited in NATA's R&D Program and offers immunological testing and sample biobanking for vaccine manufacturers, biotechnology and pharmaceutical companies, universities, and research institutes involved in translational research and development of novel therapies.
Assists scientists from all disciplines to visualise and track the movement the cells. Provides guidance in the areas of project design, training and support in image acquisition and analysis. As part of the Monash Micro Imaging network, the facility gains has access to additional expertise and imaging platforms.
This facility is dedicated to the provision of superior histological services to departmental research groups and external sources. Equipment is available to produce high quality microscopic sections of frozen and paraffin embedded material.
The APN Histopathology and Organ Pathology service operates the only full histopathology service in Australia specialising in histopathological analysis of genetically manipulated mice. The service also provides analysis of mouse models of disease and a digital imaging service for histological and multi-colour fluorescence immunohistochemical slides. The service offers a web-based image retrieval system available by secure log-in from any site and utilises medical and veterinary histopathology consultants.
AAHL is a world class high-containment facility enabling research and diagnostics on the most dangerous animal and zoonotic pathogens. Extensive laboratories and expertise at physical containment levels 3 and 4 available for collaborative and fee-for-service research.
The AMREP (Alfred Medical Research and Education Precinct) Flow Cytometry Core Facility is a state of the art, world class cell sorting and cell analysis laboratory
The Victorian Centre for Functional Genomics at the Peter MacCallum Cancer Centre provides the infrastructure and expertise to perform small interfering (siRNA), micro RNA (miRNA), long non-coding RNA (lncRNA) and lentiviral-based short hairpin RNAi (shRNAmir) knockdown screens for functional genomics studies.